Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient.
- DOI
- 10.1186/s40425-016-0125-1
- Published
- 2016
- Container
- Journal for immunotherapy of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s40425-016-0125-1,
title = {Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient.},
author = {Siddiqui I and Erreni M and van Brakel M and Debets R and Allavena P},
year = {2016},
journal = {Journal for immunotherapy of cancer},
doi = {10.1186/s40425-016-0125-1},
url = {https://doi.org/10.1186/s40425-016-0125-1}
}RIS
TY - JOUR TI - Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient. AU - Siddiqui I AU - Erreni M AU - van Brakel M AU - Debets R AU - Allavena P PY - 2016 JO - Journal for immunotherapy of cancer DO - 10.1186/s40425-016-0125-1 UR - https://doi.org/10.1186/s40425-016-0125-1 ER -
APA
I, S., M, E., M, V. B., R, D., & P, A. (2016). Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient.. Journal for immunotherapy of cancer. https://doi.org/10.1186/s40425-016-0125-1
Source records
- pubmed · retrieved 2026-11-10T13:34:44.287Z
- europe-pmc · retrieved 2026-11-10T13:34:44.294Z